Cite
HARVARD Citation
Coutre, S. et al. (2022). Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study. Open forum infectious diseases. p. . [Online].